GHK-Cu Research Powder — 10g (10,000mg)

GHK-Cu: peptide ligand and copper complex

GHK-Cu denotes a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. The peptide sequence is Gly-His-Lys, abbreviated GHK. The copper-free peptide and a copper-containing complex are different chemical species, so they must not share an unlabeled formula or molecular-weight value. A three-residue sequence describes the ligand; it does not fully describe metal coordination, protonation or the composition of a supplied material.

Public substance records illustrate this distinction. FDA GSRS represents prezatide copper as C14H22N6O4.Cu, while PubChem CID 71587328 represents a positively charged species as C14H23CuN6O4+ with molecular weight 402.92 g/mol. These are explicitly identified reference representations. They do not establish the protonation, counterion, hydration or copper-to-peptide ratio of the current product.

Coordination chemistry in research

GHK copper chemistry has been investigated using solution spectroscopy and structural methods. The solution-structure study by Freedman and colleagues addresses the complex itself. Later work by Bossak-Ahmad and colleagues examines systems containing GHK, copper(II) and another ligand, cis-urocanic acid. Those studies make chemical speciation a relevant research question rather than an assumption that every solution contains a single unchanging complex.

Experimental pH, ligand availability and mixing composition should be recorded when comparing coordination studies. A binary copper-peptide preparation and a system containing competing ligands need not have identical species distributions. For this reason, a biological result reported for one defined preparation cannot automatically be assigned to all materials sold under the general GHK-Cu name.

What an analytical report needs to distinguish

Peptide identity, total copper and metal coordination are separate questions. A mass spectrum detecting free GHK may support the identity of the ligand without establishing the amount of copper in the sample. Likewise, a measurement of total copper alone does not show which ligand binds it. Evaluate the reported analyte and sample treatment before interpreting either result.

The cited coordination research uses complementary methods such as ultraviolet-visible, circular-dichroism and electron-paramagnetic-resonance spectroscopy. These methods investigate different chemical features. Blue appearance is not a substitute for a validated purity, content or stoichiometry measurement. A report should say what was measured and the basis on which its result is expressed.

If a project depends on copper loading, specify that requirement independently of peptide purity. The analytical question should identify the intended copper-to-ligand relationship and whether free copper or free ligand must also be assessed. A single appearance observation or unqualified percentage cannot answer all of those questions.

Product format and documentation

This listing is the catalog's nominal 10 g (10,000 mg) research-powder format. The nominal package amount is a catalog specification, not a measured copper content or a molecular-weight determination. The same scientific reference applies to both GHK-Cu formats, but reports remain specific to their identified sample, lot and formulation.

For laboratory acceptance, match the label to the report and request the actual chemical-form specification where it affects interpretation. Record analytical methods, storage requirements and changes in sample condition. Chromatographic purity does not by itself establish net peptide mass, copper stoichiometry or absence of other material. This reference supplies no universal shelf life or preparation instructions.

Frequently asked questions

Related research materials

• GHK-Cu 100 mg research vials